Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Prostate Cancer Survivors and Exercise and Behavioral Counseling (BOOST)

19 dicembre 2019 aggiornato da: University of Illinois at Urbana-Champaign

A Pilot, Randomized Controlled Trial Adding Behavioral Counseling to Supervised Physical Activity in Prostate Cancer Survivors

This study will evaluate the feasibility of delivering a supervised physical activity program plus standard exercise counseling (SPA+EC) versus a supervised physical activity plus motivationally-enhanced behavioral counseling (SPA+BC) in prostate cancer survivors (PCS). Fifty participants (n=25) will be randomized to receiving SPA+EC or SPA+BC (n=25). We hypothesize that PCS receiving the SPA+BC intervention will result in greater increases in objectively-assessed physical activity compared with PCS receiving the SPA+EC intervention.

Panoramica dello studio

Stato

Completato

Condizioni

Intervento / Trattamento

Descrizione dettagliata

Physical activity (PA) has a positive impact on clinical outcomes such as improvement in overall QoL, cancer-specific mortality, reducing treatment-related toxicities, and reducing fatigue across many cancer survivor groups including PCS. Despite these benefits of regular PA, the majority of PCS are still not meeting public health PA guidelines.

Short-term supervised PA programs have been shown to improve health-related fitness and patient-reported outcomes in PCS, but PA declines significantly after the supervised intervention has been completed. Research examining the effect of short- term supervised exercise programs on motivational outcomes and longer term PA among cancer survivors is limited, especially theoretical approaches to identify key motivational outcomes for behavior change.

This study will pilot a two-armed, single blind, RCT comparing SPA+EC to SPA+BC. The proposed RCT in PCS is noteworthy given that it differs from standard approaches to supervised PA with the addition of a behavioral counseling component. This rigorous comparison condition will provide further evidence that theoretically-informed interventions are needed to adopt long-term PA maintenance.

The program's supervised exercise length will be 6 weeks, followed by a tapered contact throughout the a 6-week home-based component through 'booster' behavioral counseling delivered via telephone. In terms of study measures, objective measures of PA will be used (i.e.,accelerometry, inclinometers), and cardiorespiratory fitness will be evaluated using maximal graded exercise testing via treadmill. Additional secondary outcomes include cognitive function, quality of life, physical function, body composition, motivational outcomes, sexual functioning, masculinity, sedentary behavior, and cardiorespiratory fitness.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

27

Fase

  • Fase 2

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

  • Stati Uniti
    • Illinois
      • Urbana, Illinois, Stati Uniti, 61801
        • University of Illinois at Urbana-Champaign

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 18 anni a 80 anni (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Maschio

Descrizione

Inclusion Criteria:

  • ≥18 years and older
  • Histologically confirmed prostate cancer (Stage I-IIIa) but now cured or in remission
  • Ability and willingness to effectively communicate in English
  • Not meeting physical activity guidelines of ≥150 minutes of vigorous physical activity

Exclusion Criteria:

  • Severe coronary artery disease (Canadian Cardiovascular Society class III or greater)
  • Significant congestive heart failure (New York Heart Association class III or greater)
  • Uncontrolled pain
  • Neurological or musculoskeletal co-morbidity inhibiting exercise
  • Diagnosed psychotic, addictive or major cognitive disorders
  • Absent for more than 3 consecutive days during the 12-week intervention
  • High risk individuals (i.e., men who have symptomatic and known cardiovascular, pulmonary and/or metabolic disease) as determined by the risk stratification questionnaire

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Terapia di supporto
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Doppio

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Supervised PA Plus Behavioral Counseling
25 prostate cancer survivors will receive supervised physical activity and behavioral counseling (SPA+BC) based on the M-PAC. In addition to supervised physical activity, behavioral counseling sessions will be delivered with a PA specialist based on the Multi-process Action Control (M-PAC) framework and include behavior change techniques addressing information regarding the consequences, social support, goal setting, self-monitoring, cues and prompts, barrier identification, intention formation, planning, and habit and identity formation
Comportamentale: Supervised Physical Activity Plus Behavioral Counseling
In addition to supervised physical activity, behavioral counseling sessions will be delivered with a PA specialist based on the Multi-process Action Control (M-PAC) framework and include behavior change techniques addressing information regarding the consequences, social support, goal setting, self-monitoring, cues and prompts, barrier identification, intention formation, planning, and habit and identity formation
Comparatore attivo: Supervised PA Plus Exercise Counseling
25 prostate cancer survivors will supervised physical activity and exercise counseling (SPA+EC).In addition to the supervised exercise sessions, standard exercise counseling will be delivered by a PA specialist to teach proper PA and resistance training techniques, how to monitor intensity, and to progress PA safely and effectively to achieve the public health PA guideline.
Comportamentale: Supervised Physical Activity Plus Exercise Counseling
In addition to the supervised exercise sessions, standard exercise counseling will be delivered by a PA specialist to teach proper PA and resistance training techniques, how to monitor intensity, and to progress PA safely and effectively to achieve the public health PA guideline.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Objectively assessed physical activity
Lasso di tempo: Change in from baseline at 12 weeks
Objective Physical activity will be measured using an activity device, accelerometry (i.e., Actigraph GTX3+)
Change in from baseline at 12 weeks

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Self-reported physical activity
Lasso di tempo: Change in from baseline at 12 weeks
Self-reported physical activity will be assessed using the Godin Leisure-Time Exercise Questionnaire
Change in from baseline at 12 weeks
Physical Function
Lasso di tempo: Change in from baseline at 12 weeks
Mobility-related fitness parameters will be measured through the six-items of the Seniors' Fitness Test.
Change in from baseline at 12 weeks
General quality of life
Lasso di tempo: Change in from baseline at 12 weeks
Self-reported quality of life measured via the Functional Assessment of Cancer Therapy (FACT-G) for general quality of life.
Change in from baseline at 12 weeks
Prostate-specific quality of life
Lasso di tempo: Change in from baseline at 12 weeks
Self-reported quality of life measured via the FACT-Prostate for prostate-specific quality of life.
Change in from baseline at 12 weeks
Cancer-related fatigue
Lasso di tempo: Change in from baseline at 12 weeks
Self-reported fatigue will be assessed using the FACT-Fatigue
Change in from baseline at 12 weeks
General well-being
Lasso di tempo: Change in from baseline at 12 weeks
Self-reported Short-Form 36 will be used for assessing general well-being.
Change in from baseline at 12 weeks
Body composition
Lasso di tempo: Change in from baseline at 12 weeks
Body composition will be estimated using anthropometric measurements will be taken - height, weight and waist circumference.
Change in from baseline at 12 weeks
Cardiorespiratory fitness
Lasso di tempo: Change in from baseline at 12 weeks
Aerobic endurance capacity will be assessed by using the modified Balke sub-maximual exercise test.
Change in from baseline at 12 weeks
Cognitive function
Lasso di tempo: Change in from baseline at 12 weeks
The primary set of neuropsychological assessments will be assessed using the validated NIH Toolbox Cognition Battery. This battery consists of tests to assess Executive Function, Attention, Episodic Memory, Language, Processing Speed and Working Memory.
Change in from baseline at 12 weeks
Sexual Health
Lasso di tempo: Change in from baseline at 12 weeks
The International Index of Erectile Function (IIEF) will be used to assess sexual health including erectile function, orgasmic function, sexual desire, intercourse satisfaction and overall satisfaction.
Change in from baseline at 12 weeks
Relationship quality
Lasso di tempo: Change in from baseline at 12 weeks
The Perceived Relationship Quality Components (PRQC) Inventory will be used to assess relationship quality.
Change in from baseline at 12 weeks
Masculine self-esteem
Lasso di tempo: Change in from baseline at 12 weeks
Masculine self-esteem will be assessed using the Masculinity in Chronic Disease Inventory (MCD-I).
Change in from baseline at 12 weeks
Motivational outcomes
Lasso di tempo: Change in from baseline at 12 weeks
multi-process action control (M-PAC) framework assessing attitudes, subjective norms, perceived behavioral control, planning, habit, and identity
Change in from baseline at 12 weeks
Self-reported sedentary behavior
Lasso di tempo: Change in from baseline at 12 weeks
sitting time as measured by via self-report using the Measuring Older Adults' Sedentary Time (MOST) questionnaire which assesses sitting while watching TV, using the computer, hobbies, socializing, transportation, doing hobbies, and other activities.
Change in from baseline at 12 weeks
Objectively assessed sedentary behavior
Lasso di tempo: Change in from baseline at 12 weeks
Objective measures of sitting time will be assessed using an activity device, inclinometers (i.e., ActivPALs)
Change in from baseline at 12 weeks

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

University of Illinois at Urbana-Champaign

Investigatori

  • Investigatore principale: Linda Trinh, PhD, University of Illinois at Urbana-Champaign
  • Direttore dello studio: Edward McAuley, PhD, University of Illinois at Urbana-Champaign
  • Direttore dello studio: Art F Kramer, PhD, University of Illinois at Urbana-Champaign and Northeastern University
  • Direttore dello studio: Kendrith M Rowland, MD, Carle Cancer Center

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Pubblicazioni generali

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

6 luglio 2017

Completamento primario (Effettivo)

30 maggio 2018

Completamento dello studio (Effettivo)

30 maggio 2018

Date di iscrizione allo studio

Primo inviato

12 giugno 2017

Primo inviato che soddisfa i criteri di controllo qualità

14 giugno 2017

Primo Inserito (Effettivo)

19 giugno 2017

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

20 dicembre 2019

Ultimo aggiornamento inviato che soddisfa i criteri QC

19 dicembre 2019

Ultimo verificato

1 aprile 2017

Maggiori informazioni

Termini relativi a questo studio

Parole chiave

Termini MeSH pertinenti aggiuntivi

Altri numeri di identificazione dello studio

  • IRB (University Hospital in Lund)

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su Qualità della vita

Prove cliniche su Supervised Physical Activity Plus Behavioral Counseling

Cerca prove simili

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

CROs by country

CROs in Ukraine

Condizioni

Malattie rare

Interventi farmacologici

Supplementi dietetici

Sponsor / Collaboratori

Sedi

3
Sottoscrivi